Gillies Michael, Kuznetsova Irina, Sokolnikov Mikhail, Haylock Richard, O'Hagan Jackie, Tsareva Yulia, Labutina Elena
a Public Health England Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, United Kingdom; and.
b Southern Urals Biophysics Institute, Ozyorsk, Chelyabinsk Region, Russia.
Radiat Res. 2017 Dec;188(6):645-660. doi: 10.1667/RR14719.1. Epub 2017 Oct 6.
In this study, lung cancer risk from occupational plutonium exposure was analyzed in a pooled cohort of Mayak and Sellafield workers, two of the most informative cohorts in the world with detailed plutonium urine monitoring programs. The pooled cohort comprised 45,817 workers: 23,443 Sellafield workers first employed during 1947-2002 with follow-up until the end of 2005 and 22,374 Mayak workers first employed during 1948-1982 with follow-up until the end of 2008. In the pooled cohort 1,195 lung cancer deaths were observed (789 Mayak, 406 Sellafield) but only 893 lung cancer incidences (509 Mayak, 384 Sellafield, due to truncated follow-up in the incidence analysis). Analyses were performed using Poisson regression models, and were based on doses derived from individual radiation monitoring data using an updated dose assessment methodology developed in the study. There was clear evidence of a linear association between cumulative internal plutonium lung dose and risk of both lung cancer mortality and incidence in the pooled cohort. The pooled point estimates of the excess relative risk (ERR) from plutonium exposure for both lung cancer mortality and incidence were within the range of 5-8 per Gy for males at age 60. The ERR estimates in relationship to external gamma radiation were also significantly raised and in the range 0.2-0.4 per Gy of cumulative gamma dose to the lung. The point estimates of risk, for both external and plutonium exposure, were comparable between the cohorts, which suggests that the pooling of these data was valid. The results support point estimates of relative biological effectiveness (RBE) in the range of 10-25, which is in broad agreement with the value of 20 currently adopted in radiological protection as the radiation weighting factor for alpha particles, however, the uncertainty on this value (RBE = 21; 95% CI: 9-178) is large. The results provide direct evidence that the plutonium risks in each cohort are of the same order of magnitude but the uncertainty on the Sellafield cohort plutonium risk estimates is large, with observed risks consistent with no plutonium risk, and risks five times larger than those observed in the Mayak cohort.
在本研究中,对玛雅克和塞拉菲尔德工人的合并队列进行了职业性钚暴露导致肺癌风险的分析,这两个队列是世界上信息最丰富的队列中的两个,拥有详细的钚尿监测计划。合并队列包括45817名工人:23443名塞拉菲尔德工人于1947年至2002年首次就业,随访至2005年底;22374名玛雅克工人于1948年至1982年首次就业,随访至2008年底。在合并队列中,观察到1195例肺癌死亡(789例玛雅克工人,406例塞拉菲尔德工人),但仅893例肺癌发病(509例玛雅克工人,384例塞拉菲尔德工人,由于发病率分析中的随访截断)。分析使用泊松回归模型进行,并基于使用本研究中开发的更新剂量评估方法从个体辐射监测数据得出的剂量。有明确证据表明,在合并队列中,累积肺部钚内照射剂量与肺癌死亡率和发病率风险之间存在线性关联。60岁男性因钚暴露导致的肺癌死亡率和发病率的超额相对风险(ERR)合并点估计值在每戈瑞5 - 8的范围内。与外部伽马辐射相关的ERR估计值也显著升高,在肺部累积伽马剂量每戈瑞0.2 - 0.4的范围内。两个队列中外部和钚暴露的风险点估计值具有可比性,这表明这些数据的合并是有效的。结果支持相对生物效能(RBE)的点估计值在10 - 25的范围内,这与目前放射防护中作为α粒子辐射权重因子采用的20的值大致一致,然而,该值(RBE = 21;95%置信区间:9 - 178)的不确定性很大。结果提供了直接证据,表明每个队列中的钚风险处于相同数量级,但塞拉菲尔德队列钚风险估计值的不确定性很大,观察到的风险与无钚风险一致,且风险比玛雅克队列中观察到的风险大五倍。